Skip to main content

Table 3 Pulmonary function parameters of LCH patients with pulmonary involvement at diagnosis

From: Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

Pulmonary function test

N = 74

Normal, n (%)

12 (16.2)

Restrictive disorders, n (%)

19 (25.7)

Obstructive disorders, n (%)

12 (16.2)

Defective diffusing capacity, n (%)

60 (81.1)

Isolated diffusing capacity defect, n (%)

33 (44.6)

Restrictive and diffusing capacity defect, n (%)

16 (21.6)

Obstructive and diffusing capacity defect, n (%)

9 (12.2)

Mixed ventilation and diffusing capacity defect, n(%)

2 (2.7)

DLCO, % of predicted (median, range)

65.1 (27.6–119.0)

FEV1, % of predicted (median, range)

82.7 (26–109.8)

FEV1/FVC, % (median, range)

79.90 (50.75–106.0)

TLC, % of predicted (median, range)

87.4 (51.9–188.1)